CURRENT Medical Diagnosis and Treatment 2021 by Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow. 5040 Pages

Document Content and Description Below

HERE IS THE CONTENT Year in Review Anti-Infective Chemotherapeutic & Antibiotic Agents Bacterial & Chlamydial Infections Blood Disorders Blood Vessel & Lymphatic Disorders Breast Disorders Can... cer Common Problems in Infectious Diseases & Antimicrobial Therapy Common Symptoms Dermatologic Disorders Diabetes Mellitus & Hypoglycemia Disease Prevention & Health Promotion Disorders of Hemostasis, Thrombosis, and Antithrombotic Therapy Endocrine Disorders Gastrointestinal Disorders Genetic & Genomic Disorders Geriatric Disorders Heart Disease HIV Infection & AIDS Integrative Medicine Kidney Disease Lipid Disorders Liver, Biliary Tract, & Pancreas Disorders Mycotic Infections Nervous System Disorders Palliative Care & Pain Management Poisoning Preoperative Evaluation & Perioperative Management Protozoal & Helminthic Infections Psychiatric Disorders Pulmonary Disorders Rheumatologic, Immunologic, & Allergic Disorders Sexual & Gender Minority Health Sports Medicine & Outpatient Orthopedics Systemic Hypertension Urologic Disorders Viral & Rickettsial Infections Women's Health Issues Part 1: Disease Prevention & Health Promotion 1-01: General Approach to the Patient 1-02: Health Maintenance & Disease Prevention 1-03: Prevention of Infectious Diseases 1-04: Prevention of Cardiovascular Disease 1-05: Prevention of Osteoporosis 1-06: Prevention of Physical Inactivity 1-07: Prevention of Overweight & Obesity 1-08: Cancer Prevention 1-09: Prevention of Injuries & Violence 1-10: Prevention of Substance Use Disorder: Alcohol & Illicit Drugs Part 2: Common Symptoms 2-01: Overview: Common Symptoms 2-02: Cough 2-03: Dyspnea 2-04: Hemoptysis 2-05: Chest Pain 2-06: Palpitations 2-07: Lower Extremity Edema 2-08: Fever & Hyperthermia 2-09: Involuntary Weight Loss 2-10: Fatigue & Chronic Fatigue Syndrome 2-11: Acute Headache 2-12: Dysuria Part 3: Preoperative Evaluation & Perioperative Management 3-01: Overview: Preoperative Evaluation & Perioperative Management 3-02: Physiologic Effects of Anesthesia & Surgery 3-03: Preoperative Evaluation of the Asymptomatic Patient 3-04: Cardiac Risk Assessment & Reduction in Noncardiac Surgery 3-05: Pulmonary Evaluation in Non–Lung Resection Surgery 3-06: Preoperative Evaluation of the Patient with Liver Disease 3-07: Preoperative Hematologic Evaluation 3-08: Preoperative Neurologic Evaluation 3-09: Perioperative Management of Endocrine Diseases 3-10: Perioperative Management of Kidney Disease 3-11: Antibiotic Prophylaxis of Surgical Site Infections Part 4: Geriatric Disorders 4-01: Overview: Geriatric Disorders 4-02: General Principles of Geriatric Care 4-03: Comprehensive Assessment of the Older Adult 4-04: Management of Common Geriatric Problems Part 5: Palliative Care & Pain Management 5-01: Definition & Scope of Palliative Care 5-02: Palliation of Common Nonpain Symptoms 5-03: Care of Patients at the End of Life 5-04: Tasks After Death 5-05: Taxonomy of Pain 5-06: Acute Pain 5-07: Chronic Noncancer Pain 5-08: Cancer Pain 5-09: Pain at the End of Life 5-10: Principles of Pain Management 5-11: Pharmacologic Pain Management Strategies 5-12: Integrative Therapies & Other Pain Management 5-13: Selected Interventional Modalities for Pain Relief Part 6: Dermatologic Disorders 6-01: Overview: Dermatologic Disorders 6-02: Principles of Dermatologic Therapy 6-03: Melanocytic Nevi (Normal Moles) 6-04: Atypical Nevi 6-05: Blue Nevi 6-06: Freckles & Lentigines 6-07: Seborrheic Keratoses 6-08: Malignant Melanoma 6-09: Atopic Dermatitis 6-10: Lichen Simplex Chronicus (Circumscribed Neurodermatitis) 6-11: Psoriasis 6-12: Pityriasis Rosea 6-13: Seborrheic Dermatitis 6-14: Fungal Infections of the Skin 6-15: Cutaneous Lupus Erythematosus 6-16: Cutaneous T-Cell Lymphoma (Mycosis Fungoides) 6-17: Exfoliative Dermatitis (Exfoliative Erythroderma) 6-18: Miscellaneous Scaling Dermatoses 6-19: Intertrigo 6-20: Herpes Simplex (Cold or Fever Sore; Genital Herpes) 6-21: Variola (Smallpox) & Vaccinia 6-22: Pompholyx 6-23: Porphyria Cutanea Tarda 6-24: Dermatitis Herpetiformis 6-25: Impetigo 6-26: Contact Dermatitis 6-27: Acne Vulgaris 6-28: Rosacea 6-29: Folliculitis (Including Sycosis) 6-30: Miliaria (Heat Rash) 6-31: Mucocutaneous Candidiasis 6-32: Reactive Erythemas 6-33: Infectious Erythemas 6-34: Pemphigus 6-35: Bullous Pemphigoid 6-36: Warts 6-37: Callosities & Corns of Feet or Toes 6-38: Molluscum Contagiosum 6-39: Basal Cell Carcinoma 6-40: Squamous Cell Carcinoma 6-41: Lichen Planus 6-42: Kaposi Sarcoma 6-43: Pruritus 6-44: Anogenital Pruritus 6-45: Scabies 6-46: Pediculosis 6-47: Skin Lesions Due to Other Arthropods 6-48: Erythema Nodosum 6-49: Furunculosis (Boils) & Carbuncles 6-50: Epidermal Inclusion Cyst 6-51: Photodermatitis 6-52: Leg Ulcers Secondary to Venous Insufficiency 6-53: Pigmentary Disorders 6-54: Alopecia 6-55: Nail Disorders 6-56: Drug Eruption (Dermatitis Medicamentosa) Part 7: Disorders of the Eyes & Lids 7-01: Symptoms of Ocular Disease 7-02: Ocular Examination 7-03: Ophthalmologic Referrals 7-04: Refractive Errors 7-05: Disorders of the Lids & Lacrimal Apparatus 7-06: Conjunctivitis 7-07: Pinguecula & Pterygium 7-08: Corneal Ulcer 7-09: Infectious Keratitis 7-10: Acute Angle-Closure Glaucoma 7-11: Chronic Glaucoma 7-12: Uveitis 7-13: Cataract 7-14: Retinal Detachment 7-15: Vitreous Hemorrhage 7-16: Age-Related Macular Degeneration 7-17: Central & Branch Retinal Vein Occlusions 7-18: Central & Branch Retinal Artery Occlusions 7-19: Transient Monocular Visual Loss 7-20: Retinal Disorders Associated with Systemic Diseases 7-21: Ischemic Optic Neuropathy 7-22: Optic Neuritis 7-23: Optic Disk Swelling 7-24: Cranial Nerve Palsies 7-25: Thyroid Eye Disease (Graves Ophthalmopathy) 7-26: Orbital Cellulitis 7-27: Ocular Trauma 7-28: Ultraviolet Keratitis (Actinic Keratitis) 7-29: Chemical Conjunctivitis & Keratitis 7-30: Treatment of Ocular Disorders 7-31: Principles of Treatment of Ocular Infections 7-32: Precautions in Management of Ocular Disorders 7-33: Adverse Ocular Effects of Systemic Drugs Part 8: Ear, Nose, & Throat Disorders 8-01: Hearing Loss 8-02: Diseases of the Auricle 8-03: Diseases of the Ear Canal 8-04: Diseases of the Eustachian Tube 8-05: Diseases of the Middle Ear 8-06: Earache 8-07: Diseases of the Inner Ear 8-08: Diseases of the Central Auditory & Vestibular Systems 8-09: Otologic Manifestations of AIDS 8-10: Infections of the Nose & Paranasal Sinuses 8-11: Allergic Rhinitis 8-12: Olfactory Dysfunction 8-13: Epistaxis 8-14: Nasal Trauma 8-15: Tumors & Granulomatous Disease 8-16: Leukoplakia, Erythroplakia, Oral Lichen Planus, & Oral Cancer 8-17: Oral Candidiasis 8-18: Glossitis, Glossodynia, Dysgeusia, & Burning Mouth Syndrome 8-19: Intraoral Ulcerative Lesions 8-20: Pharyngitis & Tonsillitis 8-21: Peritonsillar Abscess & Cellulitis 8-22: Deep Neck Infections 8-23: Snoring 8-24: Acute Inflammatory Salivary Gland Disorders 8-25: Chronic Inflammatory & Infiltrative Disorders of the Salivary Glands 8-26: Salivary Gland Tumors 8-27: Dysphonia, Hoarseness, & Stridor 8-28: Common Laryngeal Disorders 8-29: Masses of the Larynx 8-30: Vocal Fold Paralysis 8-31: Tracheostomy & Cricothyrotomy 8-32: Foreign Bodies of the Trachea & Bronchi 8-33: Esophageal Foreign Bodies 8-34: Diseases Presenting as Neck Masses 8-35: Congenital Lesions Presenting as Neck Masses in Adults 8-36: Infectious & Inflammatory Neck Masses 8-37: Tumor Metastases Related to Neck Masses 8-38: Lymphoma Part 9: Pulmonary Disorders 9-01: Approach to the Patient with a Pulmonary Disorders 9-02: Disorders of the Airways 9-03: Disorders of the Upper Airways 9-04: Disorders of the Lower Airways 9-05: Approach to Management Asthma 9-06: Chronic Obstructive Pulmonary Disease 9-07: Bronchiectasis 9-08: Allergic Bronchopulmonary Mycosis 9-09: Cystic Fibrosis 9-10: Bronchiolitis 9-11: Pneumonia 9-12: Pulmonary Infiltrates in the Immunocompromised Host 9-13: Pulmonary Tuberculosis 9-14: Pulmonary Disease Caused by Nontuberculous Mycobacteria 9-15: Screening for Lung Cancer 9-16: Solitary Pulmonary Nodule 9-17: Right Middle Lobe Syndrome 9-18: Bronchial Carcinoid Tumors 9-19: Mediastinal Masses 9-20: Interstitial Lung Disease (Diffuse Parenchymal Lung Disease) 9-21: Diffuse Interstitial Pneumonias 9-22: Sarcoidosis 9-23: Pulmonary Alveolar Proteinosis 9-24: Eosinophilic Pulmonary Syndromes 9-25: Pulmonary Venous Thromboembolism 9-26: Pulmonary Hypertension 9-27: Pulmonary Vasculitis 9-28: Alveolar Hemorrhage Syndromes 9-29: Smoke Inhalation 9-30: E-cigarette- and vaping product-associated lung injury (EVALI) 9-31: Pulmonary Aspiration Syndromes 9-32: Occupational Pulmonary Diseases 9-33: Medication-Induced Lung Disease 9-34: Radiation Lung Injury 9-35: Pleuritis 9-36: Pleural Effusion 9-37: Spontaneous Pneumothorax 9-38: Disorders of Control of Ventilation 9-39: Hyperventilation Syndromes 9-40: Primary Alveolar Hypoventilation 9-41: Obesity-Hypoventilation Syndrome (Pickwickian Syndrome) 9-42: Sleep-Related Breathing Disorders 9-43: Obstructive Sleep Apnea 9-44: Acute Respiratory Failure 9-45: Acute Respiratory Distress Syndrome 9-46: Lung Transplantation Part 10: Heart Disease 10-01: Heart Disease: Symptoms & Signs 10-02: Heart Disease: Diagnostic Testing 10-03: Adult Congenital Heart Disease 10-04: Pulmonary Valve Stenosis 10-05: Coarctation of the Aorta 10-06: Atrial Septal Defect & Patent Foramen Ovale 10-07: Ventricular Septal Defect 10-08: Tetralogy of Fallot 10-09: Patent Ductus Arteriosus 10-10: Valvular Heart Disease 10-11: Mitral Stenosis 10-12: Mitral Regurgitation 10-13: Mitral Valve Prolapse Syndrome 10-14: Aortic Stenosis 10-15: Aortic Regurgitation 10-16: Tricuspid Stenosis 10-17: Tricuspid Regurgitation 10-18: Pulmonary Valve Regurgitation 10-19: Management of Anticoagulation for Patients with Prosthetic Heart Valves 10-20: Coronary Heart Disease (Atherosclerotic CAD, Ischemic Heart Disease) 10-21: Chronic Stable Angina Pectoris 10-22: Coronary Vasospasm & Angina with Normal Coronary Arteriograms 10-23: Acute Coronary Syndromes Without St-Segment Elevation 10-24: Acute Myocardial Infarction with St-Segment Elevation 10-25: Disorders of Rate & Rhythm 10-26: Mechanisms of Arrhythmias 10-27: Techniques for Evaluating Rhythm Disturbances 10-28: Sinus Arrhythmia, Bradycardia, & Tachycardia 10-29: Atrioventicular Block 10-30: Paroxysmal Supraventricular Tachycardia (PSVT) 10-31: PSVT Due to Accessory AV Pathways (Preexcitation Syndromes) 10-32: Atrial Fibrillation 10-33: Atrial Flutter 10-34: Atrial Tachycardia 10-35: Ventricular Premature Beats (Ventricular Extrasystoles) 10-36: Ventricular Tachycardia 10-37: Ventricular Fibrillation & Sudden Death 10-38: Inherited Arrhythmia Syndromes 10-39: Syncope 10-40: Heart Failure 10-41: Acute Heart Failure & Pulmonary Edema 10-42: Infectious Myocarditis 10-43: Noninfectious Myocarditis 10-44: Dilated Cardiomyopathy 10-45: Stress Cardiomyopathy 10-46: Hypertrophic Cardiomyopathy 10-47: Restrictive Cardiomyopathy 10-48: Rheumatic Fever 10-49: Diseases of the Pericardium: Anatomic & Physiologic Considerations 10-50: Acute Inflammatory Pericarditis 10-51: Pericardial Effusion & Tamponade 10-52: Constrictive Pericarditis 10-53: Pulmonary Hypertension & Pulmonary Heart Disease 10-54: Pulmonary Heart Disease (Cor Pulmonale) 10-55: Primary Cardiac Tumors 10-56: Secondary Cardiac Tumors 10-57: Cardiac Involvement in Miscellaneous Systemic Diseases 10-58: Traumatic Heart Disease 10-59: Risk of Noncardiac Surgery in the Cardiac Patient 10-60: Heart Disease & Pregnancy 10-61: Cardiovascular Changes During Pregnancy 10-62: Cardiovascular Complications of Pregnancy 10-63: Cardiovascular Screening of Athletes Part 11: Systemic Hypertension 11-01: Overview: Systemic Hypertension 11-02: How is Blood Pressure Measured & Hypertension Diagnosed? 11-03: Approach to Hypertension 11-04: Drug Therapy: Current Antihypertensive Agents 11-05: Resistant Hypertension 11-06: Hypertensive Urgencies & Emergencies Part 12: Blood Vessel & Lymphatic Disorders 12-01: Occlusive Disease: Aorta & Iliac Arteries 12-02: Occlusive Disease: Femoral & Popliteal Arteries 12-03: Occlusive Disease: Tibial & Pedal Arteries 12-04: Acute Arterial Occlusion of a Limb 12-05: Occlusive Cerebrovascular Disease 12-06: Visceral Artery Insufficiency (Intestinal Angina) 12-07: Acute Mesenteric Vein Occlusion 12-08: Thromboangiitis Obliterans (Buerger Disease) 12-09: Abdominal Aortic Aneurysm 12-10: Thoracic Aortic Aneurysms 12-11: Peripheral Artery Aneurysms 12-12: Aortic Dissection 12-13: Varicose Veins 12-14: Superficial Venous Thrombophlebitis 12-15: Chronic Venous Insufficiency 12-16: Superior Vena Caval Obstruction 12-17: Lymphangitis & Lymphadenitis 12-18: Lymphedema 12-19: Shock Part 13: Blood Disorders 13-01: Anemias 13-02: Iron Deficiency Anemia 13-03: Anemia of Chronic Disease 13-04: The Thalassemias 13-05: Sideroblastic Anemia 13-06: Vitamin B12 Deficiency 13-07: Folic Acid Deficiency 13-08: Pure Red Cell Aplasia 13-09: Hemolytic Anemias 13-10: Hereditary Spherocytosis 13-11: Paroxysmal Nocturnal Hemoglobinuria 13-12: Glucose-6-Phosphate Dehydrogenase Deficiency 13-13: Sickle Cell Anemia & Related Syndromes 13-14: Sickle Cell Trait 13-15: Sickle Thalassemia 13-16: Hemoglobin C Disorders 13-17: Unstable Hemoglobins 13-18: Autoimmune Hemolytic Anemia 13-19: Cold Agglutinin Disease 13-20: Microangiopathic Hemolytic Anemias 13-21: Aplastic Anemia 13-22: Neutropenia 13-23: Leukemias & Other Myeloproliferative Neoplasms 13-24: Polycythemia Vera 13-25: Essential Thrombocytosis 13-26: Primary Myelofibrosis 13-27: Chronic Myeloid Leukemia 13-28: Myelodysplastic Syndromes 13-29: Acute Leukemia 13-30: Chronic Lymphocytic Leukemia 13-31: Hairy Cell Leukemia 13-32: Non-Hodgkin Lymphomas 13-33: Hodgkin Lymphoma 13-34: Plasma Cell Myeloma 13-35: Monoclonal Gammopathy of Undetermined Significance 13-36: Waldenström Macroglobulinemia 13-37: Amyloidosis 13-38: Stem Cell & Immune Cell Therapeutics 13-39: Red Blood Cell Transfusions 13-40: Platelet Transfusions 13-41: Transfusion of Plasma Components Part 14: Disorders of Hemostasis, Thrombosis, & Antithrombotic Therapy 14-01: Overview of Hemostasis 14-02: Thrombocytopenia 14-03: Decreased Platelet Production 14-04: Increased Platelet Destruction 14-05: Other Conditions Causing Thrombocytopenia 14-06: Congenital Disorders of Platelet Function 14-07: Acquired Disorders of Platelet Function 14-08: Congenital Disorders of Coagulation 14-09: Acquired Disorders of Coagulation 14-10: Other Causes of Bleeding 14-11: Antithrombotic Therapy Part 15: Gastrointestinal Disorders 15-01: Dyspepsia 15-02: Nausea & Vomiting 15-03: Hiccups 15-04: Constipation 15-05: Gastrointestinal Gas 15-06: Diarrhea 15-07: Gastrointestinal Bleeding 15-08: Assessment of the Patient with Ascites 15-09: Spontaneous Bacterial Peritonitis 15-10: Malignant Ascites 15-11: Familial Mediterranean Fever 15-12: Mesothelioma 15-13: Miscellaneous Peritoneal Diseases 15-14: Diseases of the Esophagus 15-15: Gastroesophageal Reflux Disease 15-16: Infectious Esophagitis 15-17: Pill-Induced Esophagitis 15-18: Caustic Esophageal Injury 15-19: Benign Esophageal Lesions 15-20: Esophageal Motility Disorders 15-21: Chest Pain of Undetermined Origin 15-22: Gastritis & Gastropathy 15-23: Peptic Ulcer Disease 15-24: Complications of Peptic Ulcer Disease 15-25: Zollinger-Ellison Syndrome (Gastrinoma) 15-26: Benign Tumors of the Stomach 15-27: Malabsorption 15-28: Intestinal Motility Disorders 15-29: Benign Tumors of the Small Intestine 15-30: Appendicitis 15-31: Intestinal Tuberculosis 15-32: Protein-Losing Enteropathy 15-33: Irritable Bowel Syndrome 15-34: Antibiotic-Associated Colitis 15-35: Inflammatory Bowel Disease 15-36: Diverticular Disease of the Colon 15-37: Polyps of the Colon 15-38: Nonfamilial Adenomatous & Serrated Polyps 15-39: Hereditary Colorectal Cancer & Polyposis Syndromes 15-40: Hemorrhoids 15-41: Anorectal Infections 15-42: Rectal Prolapse & Solitary Rectal Ulcer Syndrome 15-43: Fecal Incontinence 15-44: Other Anal Conditions: Fissures, Abscess, Pruritus Part 16: Liver, Biliary Tract, & Pancreas Disorders 16-01: Jaundice & Evaluation of Abnormal Liver Biochemical Tests 16-02: Acute Hepatitis A 16-03: Acute Hepatitis B 16-04: Acute Hepatitis C & Other Causes of Acute Viral Hepatitis 16-05: Acute Liver Failure 16-06: Chronic Viral Hepatitis 16-07: Autoimmune Hepatitis 16-08: Alcohol-Associated Liver Disease 16-09: Drug- & Toxin-Induced Liver Injury 16-10: Nonalcoholic Fatty Liver Disease 16-11: Cirrhosis 16-12: Primary Biliary Cholangitis 16-13: Hemochromatosis 16-14: Wilson Disease 16-15: Hepatic Venous Outflow Obstruction (Budd-Chiari Syndrome) 16-16: The Liver in Heart Failure 16-17: Noncirrhotic Portal Hypertension 16-18: Pyogenic Hepatic Abscess 16-19: Benign Liver Neoplasms 16-20: Cholelithiasis (Gallstones) 16-21: Acute Cholecystitis 16-22: Pre- & Postcholecystectomy Syndromes 16-23: Choledocholithiasis & Cholangitis 16-24: Biliary Stricture 16-25: Primary Sclerosing Cholangitis 16-26: Acute Pancreatitis 16-27: Chronic Pancreatitis Part 17: Breast Disorders 17-01: Fibrocystic Condition 17-02: Fibroadenoma of the Breast 17-03: Nipple Discharge 17-04: Fat Necrosis 17-05: Breast Abscess 17-06: Disorders of the Augmented Breast 17-07: Carcinoma of the Female Breast 17-08: Carcinoma of the Male Breast Part 18: Gynecologic Disorders 18-01: Premenopausal Abnormal Uterine Bleeding 18-02: Postmenopausal Uterine Bleeding 18-03: Leiomyoma of the Uterus (Fibroid Tumor) 18-04: Cervical Polyps 18-05: Endometriosis 18-06: Pelvic Pain 18-07: Pelvic Organ Prolapse 18-08: Premenstrual Syndrome 18-09: Menopausal Syndrome 18-10: Polycystic Ovary Syndrome 18-11: Infertility Updated! 18-12: Contraception 18-13: Female Sexual Dysfunction 18-14: Sexual Violence 18-15: Bartholin Duct Cysts & Abscesses 18-16: Vaginitis 18-17: Pelvic Inflammatory Disease (Salpingitis, Endometritis) 18-18: Condyloma Acuminata 18-19: Cervical Intraepithelial Neoplasia (CIN) (Dysplasia of the Cervix) 18-20: Carcinoma of the Cervix 18-21: Carcinoma of the Endometrium 18-22: Carcinoma of the Vulva 18-23: Ovarian Cancer & Ovarian Tumors Part 19: Obstetrics & Obstetric Disorders 19-01: Diagnosis of Pregnancy 19-02: Essentials of Prenatal Care 19-03: Nutrition in Pregnancy 19-04: Prevention of Rhesus Alloimmunization 19-05: Lactation 19-06: Travel & Immunizations During Pregnancy 19-07: Vomiting of Pregnancy & Hyperemesis Gravidarum 19-08: Spontaneous Abortion 19-09: Recurrent Abortion 19-10: Ectopic Pregnancy 19-11: Gestational Trophoblastic Disease (Hydatidiform Mole & Choriocarcinoma) 19-12: Preeclampsia-Eclampsia 19-13: Preterm Labor 19-14: Third-Trimester Bleeding 19-15: Puerperal Mastitis 19-16: Chorioamnionitis & Metritis 19-17: Anemia in Pregnancy 19-18: Antiphospholipid Syndrome in Pregnancy 19-19: Thyroid Disease in Pregnancy 19-20: Diabetes Mellitus in Pregnancy 19-21: Chronic Hypertension in Pregnancy 19-22: Heart Disease in Pregnancy 19-23: Asthma in Pregnancy 19-24: Seizure Disorders in Pregnancy 19-25: Urinary Tract Infection in Pregnancy 19-26: Group B Streptococcal Infection in Pregnancy 19-27: Varicella in Pregnancy 19-28: Tuberculosis in Pregnancy 19-29: HIV/AIDS During Pregnancy 19-30: Maternal Hepatitis B & C Carrier State 19-31: Herpes Genitalis in Pregnancy 19-32: Syphilis, Gonorrhea, & Chlamydia Trachomatis Infection in Pregnancy 19-33: Gastrointestinal, Hepatic, & Biliary Disorders of Pregnancy 19-34: Cholelithiasis & Cholecystitis in Pregnancy 19-35: Acute Fatty Liver of Pregnancy 19-36: Intrahepatic Cholestasis of Pregnancy 19-37: Appendicitis in Pregnancy 19-38: Carcinoma of the Breast in Pregnancy 19-39: Ovarian Tumors in Pregnancy Part 20: Rheumatologic, Immunologic, & Allergic Disorders 20-01: Rheumatologic Disorders 20-02: Degenerative Joint Disease (Osteoarthritis) 20-03: Crystal Deposition Arthritis 20-04: Autoimmune Diseases 20-05: Rheumatoid Arthritis 20-06: Adult Still Disease 20-07: Systemic Lupus Erythematosus 20-08: Drug-Induced Lupus 20-09: Antiphospholipid Syndrome 20-10: Raynaud Phenomenon 20-11: Scleroderma (Systemic Sclerosis) 20-12: Idiopathic Inflammatory Myopathies (Polymyositis & Dermatomyositis) 20-13: Mixed Connective Tissue Disease & Overlap Syndromes 20-14: Sjögren Syndrome 20-15: IgG4-Related Disease 20-16: Vasculitis Syndromes 20-17: Polymyalgia Rheumatica & Giant Cell Arteritis 20-18: Takayasu Arteritis 20-19: Polyarteritis Nodosa 20-20: Granulomatosis with Polyangiitis 20-21: Microscopic Polyangiitis 20-22: Eosinophilic Granulomatosis with Polyangiitis 20-23: Levamisole-Associated Purpura 20-24: Cryoglobulinemia 20-25: IgA Vasculitis 20-26: Relapsing Polychondritis 20-27: Behçet Syndrome 20-28: Primary Angiitis of the Central Nervous System 20-29: Livedo Reticularis & Livedo Racemosa 20-30: Seronegative Spondyloarthropathies 20-31: Ankylosing Spondylitis 20-32: Psoriatic Arthritis 20-33: Reactive Arthritis 20-34: Inflammatory Bowel Disease Associated Spondyloarthritis 20-35: Nongonococcal Acute Bacterial (Septic) Arthritis 20-36: Gonococcal Arthritis 20-37: Rheumatic Manifestations of HIV Infection 20-38: Viral Arthritis 20-39: Acute Pyogenic Osteomyelitis 20-40: Mycotic Infections of Bones & Joints 20-41: Spinal Tuberculosis (Pott Disease) 20-42: Tuberculous Arthritis 20-43: Arthritis In Sarcoidosis 20-44: Tumors & Tumor-Like Lesions of Bone 20-45: Thoracic Outlet Syndromes 20-46: Fibromyalgia 20-47: Complex Regional Pain Syndrome 20-48: Rheumatologic Manifestations of Cancer 20-49: Neurogenic Arthropathy (Charcot Joint) 20-50: Palindromic Rheumatism 20-51: Osteonecrosis (Avascular Necrosis of Bone) 20-52: Some Orthopedic Procedures for Arthritic Joints 20-53: Allergic & Immunologic Disorders 20-54: Immediate Hypersensitivity 20-55: Allergy Testing 20-56: Delayed Hypersensitivity 20-57: Primary Immunodeficiency Disorders in Adults Part 21: Electrolyte & Acid-Base Disorders 21-01: Assessment of the Patient for Electrolyte and Fluid Disorders 21-02: Hyponatremia 21-03: Hypernatremia 21-04: Hypokalemia 21-05: Hyperkalemia 21-06: Disorders of Calcium Concentration 21-07: Hypocalcemia 21-08: Hypercalcemia 21-09: Disorders of Phosphorus Concentration 21-10: Hypophosphatemia 21-11: Hyperphosphatemia 21-12: Disorders of Magnesium Concentration 21-13: Hypomagnesemia 21-14: Hypermagnesemia 21-15: Acid-Base Disorders 21-16: Mixed Acid-Base Disorders 21-17: Metabolic Acidosis 21-18: Increased Anion Gap Acidosis 21-19: Normal Anion Gap Acidosis 21-20: Metabolic Alkalosis 21-21: Respiratory Acidosis (Hypercapnia) 21-22: Respiratory Alkalosis 21-23: Fluid Management Part 22: Kidney Disease 22-01: Overview: Kidney Disease 22-02: Assessment of Kidney Disease 22-03: Imaging Studies of the Kidney 22-04: Kidney Biopsy 22-05: Acute Kidney Injury 22-06: Acute Tubular Necrosis 22-07: Rhabdomyolysis 22-08: Interstitial Nephritis 22-09: Glomerulonephritis 22-10: Cardiorenal Syndrome 22-11: Chronic Kidney Disease 22-12: Renal Artery Stenosis 22-13: Glomerular Diseases 22-14: Nephritic Spectrum Glomerular Diseases 22-15: Nephrotic Spectrum Glomerular Diseases 22-16: Minimal Change Disease 22-17: Focal Segmental Glomerulosclerosis 22-18: Membranous Nephropathy 22-19: Diabetic Nephropathy 22-20: HIV-Associated Nephropathy 22-21: Renal Amyloidosis 22-22: Tubulointerstitial Diseases 22-23: Chronic Tubulointerstitial Diseases 22-24: Cystic Diseases of the Kidney 22-25: Simple or Solitary Cysts of the Kidney 22-26: Autosomal Dominant Polycystic Kidney Disease 22-27: Medullary Sponge Kidney 22-28: Juvenile Nephronophthisis-Medullary Cystic Disease 22-29: Plasma Cell Myeloma 22-30: Sickle Cell Disease 22-31: Renal Manifestations of Tuberculosis 22-32: Gout & The Kidney 22-33: Nephrogenic Systemic Fibrosis 22-34: The Kidney & Aging Part 23: Urologic Disorders 23-01: Urologic Evaluation 23-02: Hematuria 23-03: Genitourinary Tract Infections 23-04: Interstitial Cystitis 23-05: Urinary Stone Disease 23-06: Male Erectile Dysfunction & Sexual Dysfunction 23-07: Male Infertility 23-08: Benign Prostatic Hyperplasia Part 24: Nervous System Disorders 24-01: Headache 24-02: Facial Pain 24-03: Epilepsy 24-04: Dysautonomia 24-05: Sensory Disturbances 24-06: Weakness & Paralysis 24-07: Transient Ischemic Attacks 24-08: Stroke 24-09: Intracranial & Spinal Mass Lesions 24-10: Nonmetastatic Neurologic Complications of Malignant Disease 24-11: Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) 24-12: Selected Neurocutaneous Diseases 24-13: Movement Disorders 24-14: Dementia 24-15: Wernicke Encephalopathy & Korsakoff Syndrome 24-16: Stupor & Coma 24-17: Head Injury 24-18: Multiple Sclerosis 24-19: Neuromyelitis Optica 24-20: Vitamin E Deficiency 24-21: Spasticity 24-22: Myelopathies in AIDS 24-23: Myelopathy of Human T-Cell Leukemia Virus Infection 24-24: Subacute Combined Degeneration of the Spinal Cord 24-25: Spinal Trauma 24-26: Syringomyelia 24-27: Degenerative Motor Neuron Diseases 24-28: Peripheral Neuropathies 24-29: Polyneuropathies & Mononeuritis Multiplex 24-30: Mononeuropathies 24-31: Bell Palsy 24-32: Discogenic Neck Pain 24-33: Brachial & Lumbar Plexus Lesions 24-34: Disorders of Neuromuscular Transmission 24-35: Myopathic Disorders 24-36: Periodic Paralysis Syndromes Part 25: Psychiatric Disorders 25-01: Psychiatric Assessment 25-02: Treatment Approaches for Psychiatric Treatment Disorders 25-03: Psychiatric Adjustment Disorders 25-04: Psychiatric Trauma & Stressor-Related Disorders 25-05: Anxiety Disorders 25-06: Obsessive-Compulsive Disorder & Related Disorders 25-07: Somatic Symptom Disorders (Abnormal Illness Behaviors) 25-08: Chronic Pain Disorders 25-09: Psychosexual Disorders 25-10: Personality Disorders 25-11: Schizophrenia Spectrum Disorders 25-12: Mood Disorders (Depression & Mania) 25-13: Attention-Deficit/Hyperactivity Disorder 25-14: Autism Spectrum Disorders 25-15: Sleep-Wake Disorders 25-16: Disorders of Aggression 25-17: Substance Use Disorders 25-18: Alcohol Use Disorder (Alcoholism) 25-19: Other Drug & Substance Use Disorders 25-20: Neurocognitive Disorders 25-21: Psychiatric Problems Associated with Hospitalization & Illness Part 26: Endocrine Disorders 26-01: Anterior Hypopituitarism 26-02: Central Diabetes Insipidus 26-03: Acromegaly & Gigantism 26-04: Hyperprolactinemia 26-05: Nonfunctioning Pituitary Adenomas 26-06: Thyroid Testing 26-07: Thyroiditis 26-08: Hypothyroidism & Myxedema 26-09: Hyperthyroidism (Thyrotoxicosis) 26-10: Thyroid Nodules & Multinodular Goiter 26-11: Thyroid Cancer 26-12: Iodine Deficiency Disorder & Endemic Goiter 26-13: Diseases of the Parathyroids 26-14: Hypoparathyroidism & Pseudohypoparathyroidism 26-15: Hyperparathyroidism 26-16: Metabolic Bone Disease 26-17: Osteopenia 26-18: Osteoporosis 26-19: Rickets & Osteomalacia 26-20: Paget Disease of Bone (Osteitis Deformans) 26-21: Primary Adrenal Insufficiency (Addison Disease) 26-22: Cushing Syndrome (Hypercortisolism) 26-23: Primary Aldosteronism 26-24: Pheochromocytoma & Paraganglioma 26-25: Incidentally Discovered Adrenal Masses 26-26: Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS) & Carcinoid Tumors 26-27: Men Types 1-4 26-28: Other Syndromes of Multiple Endocrine Neoplasia 26-29: Male Hypogonadism 26-30: Cryptorchism 26-31: Gynecomastia 26-32: Hirsutism & Virilization 26-33: Primary Amenorrhea 26-34: Secondary Amenorrhea & Menopause 26-35: Turner Syndrome (Gonadal Dysgenesis) 26-36: Clinical use of Corticosteroids Part 27: Diabetes Mellitus & Hypoglycemia 27-01: Diabetes Mellitus 27-02: Diabetic Coma 27-03: Diabetic Ketoacidosis 27-04: Hyperglycemic Hyperosmolar State 27-05: Lactic Acidosis 27-06: The Hypoglycemic States 27-07: Hypoglycemia Due to Pancreatic B Cell Tumors 27-08: Nonislet Cell Tumor Hypoglycemia 27-09: Postprandial Hypoglycemia 27-10: Factitious Hypoglycemia 27-11: Hypoglycemia Due to Insulin Receptor Antibodies 27-12: Medication- & Ethanol-Induced Hypoglycemia; was Medication-Induced Hypoglycemia Part 28: Lipid Disorders 28-01: Overview: Lipid Disorders 28-02: Lipids & Lipoproteins 28-03: Lipoproteins & Atherogenesis 28-04: Lipid Fractions & the Risk of Coronary Heart Disease 28-05: Therapeutic Effects of Lowering Cholesterol 28-06: Secondary Conditions that Affect Lipid Metabolism 28-07: Lipid Disorders: Clinical Presentations 28-08: Screening & Treatment Of High Blood Cholesterol 28-09: Treatment of High LDL Cholesterol 28-10: High Blood Triglycerides Part 29: Nutritional Disorders 29-01: Nutritional Requirements 29-02: Assessment of Nutritional Status 29-03: Protein–Energy Malnutrition 29-04: Obesity 29-05: Anorexia Nervosa 29-06: Bulimia Nervosa 29-07: Disorders of Vitamin Metabolism 29-08: Thiamine (B1) Deficiency 29-09: Thiamine Toxicity 29-10: Riboflavin (B2) Deficiency 29-11: Riboflavin Toxicity 29-12: Niacin Deficiency 29-13: Niacin Toxicity 29-14: Vitamin B6 Deficiency 29-15: Vitamin B6 Toxicity 29-16: Vitamin C (Ascorbic Acid) Deficiency 29-17: Vitamin C Toxicity 29-18: Vitamin A Deficiency 29-19: Vitamin A Toxicity 29-20: Vitamin E Deficiency 29-21: Vitamin E Toxicity 29-22: Diet Therapy 29-23: Diets that Alter Consistency 29-24: Diets that Restrict Nutrients 29-25: Diets that Supplement Nutrients 29-26: Nutritional Support 29-27: Indications for Nutritional Support 29-28: Nutritional Requirements 29-29: Enteral Nutritional Support Solutions 29-30: Complications of Enteral Nutritional Support 29-31: Parenteral Nutritional Support Solutions 29-32: Complications of Parenteral Nutritional Support 29-33: Patient Monitoring During Nutritional Support Part 30: Common Problems in Infectious Diseases & Antimicrobial Therapy 30-01: Fever of Unknown Origin (FUO) 30-02: Infections in the Immunocompromised Patient 30-03: Health Care–Associated Infections 30-04: Infections of the Central Nervous System 30-05: Animal & Human Bite Wounds 30-06: Sexually Transmitted Diseases 30-07: Infections in Persons who Inject Drugs 30-08: Acute Infectious Diarrhea 30-09: Infectious Diseases in the Returning Traveler 30-10: Traveler’s Diarrhea 30-11: Selected Principles of Antimicrobial Therapy 30-12: Hypersensitivity 30-13: Recommended Immunization of Infants, Children, & Adolescents 30-14: Recommended Immunization for Adults 30-15: Recommended Immunizations for Travelers 30-16: Vaccine Safety Part 31: HIV Infection & AIDS 31-01: Overview: HIV Infection & AIDS 31-02: HIV Infection & AIDS: Clinical Findings 31-03: HIV Infection & AIDS: Differential Diagnosis 31-04: HIV Infection & AIDS: Complications 31-05: HIV Infection & AIDS: Prevention 31-06: HIV Infection & AIDS: Treatment 31-07: HIV Infection & AIDS: Course & Prognosis Part 32: Viral & Rickettsial Infections 32-01: Human Herpesviruses 32-02: Major Vaccine-Preventable Viral Infections 32-03: Other Neurotropic Viruses 32-04: Viral Hemorrhagic Fevers 32-05: Other Systemic Viral Diseases 32-06: Common Viral Respiratory Infections 32-07: Adenovirus Infections 32-08: Other Exanthematous Viral Infections 32-09: Viruses & Gastroenteritis 32-10: Enteroviruses that Produce Several Syndromes 32-11: Typhus Group 32-12: Spotted Fevers 32-13: Other Rickettsial & Rickettsial-Like Diseases 32-14: Kawasaki Disease Part 33: Bacterial & Chlamydial Infections 33-01: Streptococcal Infections 33-02: Enterococcal Infections 33-03: Pneumococcal Infections 33-04: Staphylococcus Aureus Infections 33-05: Clostridial Diseases 33-06: Anthrax 33-07: Diphtheria 33-08: Listeriosis 33-09: Infective Endocarditis 33-10: Bordetella Pertussis Infection (Whooping Cough) 33-11: Other Bordetella Infections 33-12: Meningococcal Meningitis 33-13: Infections Caused by Haemophilus Species 33-14: Infections Caused by Moraxella Catarrhalis 33-15: Legionnaires Disease 33-16: Gram-Negative Bacteremia & Sepsis 33-17: Salmonellosis 33-18: Shigellosis 33-19: Gastroenteritis Caused by Escherichia Coli 33-20: Cholera 33-21: Infections Caused by Other Vibrio Species 33-22: Infections Caused by Campylobacter Species 33-23: Brucellosis 33-24: Tularemia 33-25: Plague 33-26: Gonococcal Infections 33-27: Chancroid 33-28: Granuloma Inguinale 33-29: Bartonella Species 33-30: Elizabethkingia Species 33-31: Anaerobic Infections 33-32: Procalcitonin 33-33: Actinomycosis 33-34: Nocardiosis 33-35: Nontuberculous Mycobacterial Diseases 33-36: Mycobacterium Tuberculosis Infections 33-37: Tuberculous Meningitis 33-38: Leprosy (Hansen Disease) 33-39: Infections Caused by Chlamydiae 33-40: Chlamydia Trachomatis Infections 33-41: Chlamydophila Psittaci & Psittacosis (Ornithosis) 33-42: Chlamydophila Pneumoniae Infection Part 34: Spirochetal Infections 34-01: Syphilis: Natural History & Principles of Diagnosis & Treatment… 34-02: Syphilis: Course & Prognosis 34-03: Clinical Stages of Syphilis 34-04: Non–Sexually Transmitted Treponematoses 34-05: Yaws 34-06: Pinta 34-07: Endemic Syphilis (Bejel) 34-08: Relapsing Fever 34-09: Rat-Bite Fever 34-10: Leptospirosis 34-11: Lyme Disease (Lyme Borreliosis) 34-12: Borrelia Miyamotoi Disease Part 35: Protozoal & Helminthic Infections 35-01: African Trypanosomiasis (Sleeping Sickness) 35-02: American Trypanosomiasis (Chagas Disease) 35-03: Leishmaniasis 35-04: Malaria 35-05: Babesiosis 35-06: Toxoplasmosis 35-07: Amebiasis 35-08: Infections with Pathogenic Free-Living Amoebas 35-09: Coccidiosis (Cryptosporidiosis, Isosporiasis, Cyclosporiasis, Sarcocystosis) & Microsporidiosis 35-10: Giardiasis 35-11: Other Intestinal Flagellate Infections 35-12: Trichomoniasis 35-13: Schistosomiasis (Bilharziasis) 35-14: Fascioliasis 35-15: Clonorchiasis & Opisthorchiasis 35-16: Paragonimiasis 35-17: Intestinal Flukes 35-18: Noninvasive Cestode Infections 35-19: Invasive Cestode Infections 35-20: Ascariasis 35-21: Trichuriasis 35-22: Hookworm Disease 35-23: Strongyloidiasis 35-24: Enterobiasis 35-25: Dracunculiasis 35-26: Trichinosis 35-27: Angiostrongyliasis 35-28: Gnathostomiasis 35-29: Toxocariasis 35-30: Cutaneous Larva Migrans (Creeping Eruption) 35-31: Anisakiasis 35-32: Lymphatic Filariasis 35-33: Onchocerciasis 35-34: Loiasis Part 36: Mycotic Infections 36-01: Overview: Mycotic Infections 36-02: Candidiasis 36-03: Histoplasmosis 36-04: Coccidioidomycosis 36-05: Pneumocystosis (Pneumocystis jirovecii Pneumonia) 36-06: Cryptococcosis 36-07: Aspergillosis 36-08: Mucormycosis 36-09: Blastomycosis 36-10: Paracoccidioidomycosis (South American Blastomycosis) 36-11: Sporotrichosis 36-12: Talaromyces (Formerly Penicillium) Marneffei Infections 36-13: Chromoblastomycosis (Chromomycosis) 36-14: Mycetoma (Eumycetoma & Actinomycetoma) 36-15: Other Opportunistic Mold Infections 36-16: Household Molds 36-17: Antifungal Therapy Part 37: Disorders Related to Environmental Emergencies 37-01: Cold & Heat 37-02: Disorders Due to Heat 37-03: Accidental Systemic Hypothermia 37-04: Hypothermia of the Extremities 37-05: Frostnip & Chilblain (Erythema Pernio) 37-06: Immersion Foot or Trench Foot 37-07: Frostbite 37-08: Cold Urticaria 37-09: Drowning 37-10: Thermal Burns 37-11: Electrical Injury 37-12: Radiation Exposure 37-13: Dysbarism & Decompression Sickness 37-14: High-Altitude Illness 37-15: Safety of Air Travel & Selection of Patients for Air Travel Part 38: Poisoning 38-01: Initial Evaluation: Poisoning or Overdose 38-02: Poisoning or Overdose: The Symptomatic Patient 38-03: Poisoning or Overdose–Related Coma 38-04: Poisoning or Overdose–Related Hypothermia 38-05: Poisoning or Overdose–Related Hypotension 38-06: Poisoning or Overdose–Related Hypertension 38-07: Poisoning or Overdose–Related Arrhythmias 38-08: Poisoning or Overdose–Related Seizures 38-09: Poisoning or Overdose–Related Hyperthermia 38-10: Antidotes 38-11: Decontamination of the Skin 38-12: Decontamination of the Eyes 38-13: Gastrointestinal Decontamination 38-14: Diagnosis of Poisoning 38-15: Acetaminophen Overdose 38-16: Acids, Corrosive Poisoning 38-17: Alkalies Poisoning 38-18: Amphetamines & Cocaine Overdose 38-19: Anticoagulants Overdose 38-20: Anticonvulsants Overdose 38-21: Antipsychotic Drug Overdose 38-22: Arsenic Poisoning 38-23: Atropine & Anticholinergics Overdose 38-24: Beta-Adrenergic Blockers Overdose 38-25: Calcium Channel Blockers Overdose 38-26: Carbon Monoxide Poisoning 38-27: Chemical Warfare: Nerve Agents 38-28: Chemical Warfare: Ricin 38-29: Chlorinated Insecticides Posioning 38-30: Clonidine & Other Sympatholytic Antihypertensives Overdose 38-31: Cyanide Poisoning 38-32: Dietary Supplements & Herbal Products Overdose 38-33: Digitalis & Other Cardiac Glycosides Overdose 38-34: Ethanol, Benzodiazepines, & Other Sedative-Hypnotic Agents Overdose 38-35: Gamma-Hydroxybutyrate (GHB) Overdose 38-36: Hypoglycemic Drugs Overdose 38-37: Iron Overdose 38-38: Isoniazid Overdose 38-39: Lead Poisoning 38-40: Lithium Poisoning 38-41: LSD & Other Hallucinogens Overdose 38-42: Marijuana & Synthetic Cannabinoids 38-43: Mercury Poisoning 38-44: Methanol & Ethylene Glycol Poisoning 38-45: Methemoglobinemia-Inducing Agents Poisoning 38-46: Monoamine Oxidase Inhibitors Overdose 38-47: Mushroom Poisoning 38-48: Opiate & Opioid Overdose 38-49: Paraquat Poisoning 38-50: Pesticides: Cholinesterase Inhibitors Poisoning 38-51: Petroleum Distillates & Solvents Poisoning 38-52: Quinidine & Related Antiarrhythmics Overdose 38-53: Salicylates Overdose 38-54: Seafood Poisonings 38-55: Snake Bites 38-56: Spider Bites & Scorpion Stings 38-57: Theophylline & Caffeine Overdose 38-58: Tricyclic & Other Antidepressants Overdose Part 39: Cancer 39-01: Introduction to Cancer 39-02: The Paraneoplastic Syndromes 39-03: Bronchogenic Carcinoma 39-04: Pulmonary Metastasis 39-05: Mesothelioma 39-06: Hepatocellular Carcinoma 39-07: Carcinoma of the Biliary Tract 39-08: Carcinoma of the Pancreas & Ampulla of Vater 39-09: Esophageal Cancer 39-10: Gastric Adenocarcinoma 39-11: Gastric Lymphoma 39-12: Gastric Neuroendocrine Tumors 39-13: Gastrointestinal Mesenchymal Tumors 39-14: Malignancies of the Small Intestine 39-15: Colorectal Cancer 39-16: Carcinoma of the Anus 39-31: Toxicity & Dose Modification of Chemotherapeutic Agents 39-17: Prostate Cancer 39-18: Bladder Cancer 39-19: Cancers of the Ureter & Renal Pelvis 39-20: Renal Cell Carcinoma 39-21: Other Primary Tumors of the Kidney 39-22: Secondary Cancers of the Kidney 39-23: Testicular Cancers (Germ Cell Tumors) 39-24: Secondary Cancers of the Testis 39-25: Cancer-Related Spinal Cord Compression 39-26: Malignant Effusions 39-27: Cancer-Related Hypercalcemia 39-28: Hyperuricemia & Tumor Lysis Syndrome 39-29: Infections in Cancer Patients 39-30: Systemic Cancer Therapy 39-32: Prognosis in Patients Receiving Chemotherapy Part 40: Genetic & Genomic Disorders 40-01: Overview: Genetic & Genomic Disorders 40-02: Genes & Chromosomes 40-03: Gene Mutation 40-04: Genes in Individuals 40-05: Genes in Families 40-06: Genetics in Disorders of Multifactorial Causation 40-07: Chromosomal Aberrations 40-08: The Techniques of Medical Genetics 40-09: Cytogenetics & Cytogenomics 40-10: Biochemical Genetics 40-11: DNA Analysis 40-12: Prenatal Diagnosis of Genetic Disorders 40-13: Neoplasia: Cytogenomic & DNA Analysis 40-14: Evolution of Gene Therapy 40-15: Acute Intermittent Porphyria 40-16: Down Syndrome 40-17: Familial Hypercholesterolemia 40-18: Fragile X Mental Retardation 40-19: Gaucher Disease 40-20: Disorders of Homocysteine Metabolism 40-21: Klinefelter Syndrome 40-22: Marfan Syndrome 40-23: Hereditary Hemorrhagic Telangiectasia Part 41: Sports Medicine & Outpatient Orthopedics 41-01: General Approach to Musculoskeletal Injuries 41-02: Musculoskeletal Injuries of the Shoulder 41-03: Spine Problems 41-04: Upper Extremity Musculoskeletal Injuries 41-05: Musculoskeletal Injuries of the Hip 41-06: Musculoskeletal Injuries of the Knee 41-07: Ankle Injuries Part 42: Lesbian, Gay, Bisexual, & Transgender Health 42-01: Health Care for Sexual & Gender Minority Patients 42-02: Health Care for Lesbian & Bisexual Women 42-03: Health Care for Gay & Bisexual Men 42-04: Transgender Health & Disease Prevention Part e1: Anti-Infective Chemotherapeutic & Antibiotic Agents e1-01: Penicillins e1-02: Cephalosporins e1-03: Other Beta-Lactam Medications e1-04: Erythromycin Group (Macrolides) e1-05: Tetracycline Group e1-06: Tetracycline Derivatives e1-07: Aminoglycosides e1-08: Polymyxins e1-09: Lefamulin e1-10: Antituberculous Medications e1-11: Alternative Medications in Tuberculosis Treatment e1-12: Rifamycins e1-13: Sulfonamides & Antifolate Medications e1-14: Sulfones e1-15: Specialized Medications Used Against Bacteria: Bacitracin, Mupirocin, Clindamycin, Metronidazole & Tinidazole, Vancomycin, Bezlotoxumab e1-16: Streptogramins e1-17: Oxazolidinediones e1-18: Daptomycin e1-19: Telavancin, Dalbavancin, Oritavancin e1-20: Quinolones e1-21: Pentamidine & Atovaquone e1-22: Urinary Antiseptics e1-23: Antifungal Medications e1-24: Antiviral Chemotherapy Part e2: Diagnostic Testing & Medical Decision Making e2-01: Overview: Diagnostic Testing & Medical Decision Making e2-02: Benefits, Risks, & Costs of Diagnostic Tests e2-03: Diagnostic Test Preparation e2-04: Diagnostic Test Characteristics e2-05: Use of Tests in Diagnosis & Management e2-06: Likelihood Ratios & Odds-Probability Conversion in Medical Decision-Making Part e3: Information Technology in Patient Care e3-01: Overview: Information Technology in Patient Care e3-02: Patient Confidentiality & Information Technology e3-03: Clinical Uses of E-Mail e3-04: Electronic Health Records e3-05: Computerized Provider Order Entry e3-06: Clinical Decision Support e3-07: Social Media & Websites in Clinical Practice e3-08: Mobile Computing for Clinicians e3-09: Telemedicine Part e4: Integrative Medicine e4-01: Overview: Integrative Medicine e4-02: Herbal & Dietary Supplements e4-03: Botanical Medicines e4-04: Non-Botanical Dietary Supplements e4-05: Acupuncture e4-06: Mind-Body Medicine e4-07: Meditation e4-08: Guided Imagery e4-09: Biofeedback e4-10: Hypnosis e4-11: Yoga e4-12: Tai Chi Part e5: Podiatric Disorders e5-01: Bunion e5-02: Hammertoe e5-03: Hallux Limitus e5-04: Fifth Metatarsal Fracture e5-05: Morton Neuroma e5-06: Onychocryptosis (Ingrown Nail) e5-07: Achilles Tendonitis e5-08: Plantar Fasciitis e5-09: Plantar Plate Injuries (Predislocation Syndrome) e5-10: Flatfoot (Pes Planus) Part e6: Women's Health Issues e6-01: Overview: Women's Health Issues e6-02: Preventive Health Care in Women e6-03: Cardiovascular Disease Prevention in Women e6-04: Cancer Prevention in Women e6-05: Osteoporosis Prevention in Women e6-06: Prevention of Sexually Transmitted Infections in Women e6-07: Depression Screening in Women e6-08: Intimate Partner Violence Issues for Women e6-09: Human Trafficking e6-10: Eating Disorders in Women e6-11: Sexuality & Sexual Health in Women e6-12: Low Sexual Desire in Women e6-13: Chronic Pelvic Pain in Women e6-14: Mastalgia e6-15: The Palpable Breast Mass e6-16: Asymptomatic Ovarian Masses e6-17: Female Pattern Hair Loss Part e7: Appendix: Therapeutic Drug Monitoring & Laboratory Reference Intervals, & Pharmacogenetic Testing e7-01: Therapeutic Drug Monitoring e7-02: Reference Intervals for Commonly Used Tests e7-03: Selected Pharmacogenetic Tests: Clinical Relevance e7-04: Commonly Used Blood Specimen Collection Tubes [Show More]

Last updated: 1 year ago

Preview 1 out of 2 pages